HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 86 filers reported holding HARPOON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $191,000 | – | 24,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $48,525,000 | 11.21% |
| MPM BioImpact LLC | 7,796,844 | $129,506,000 | 11.18% |
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $75,151,000 | 10.64% |
| Altium Capital Management LP | 101,994 | $1,694,000 | 0.63% |
| Avidity Partners Management LP | 785,000 | $13,039,000 | 0.42% |
| DAFNA Capital Management LLC | 85,119 | $1,414,000 | 0.42% |
| Artal Group S.A. | 800,000 | $13,288,000 | 0.28% |
| Orbimed Advisors | 1,835,704 | $30,491,000 | 0.27% |
| GSA CAPITAL PARTNERS LLP | 83,673 | $1,390,000 | 0.23% |
| Cormorant Asset Management, LP | 570,600 | $9,478,000 | 0.23% |